10 Best Small-Cap Value Stocks to Buy
Small-cap stocks are the real thing in an equity market under immense pressure amid geopolitical and monetary policy uncertainties.
Innoviva Inc. (INVA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 4,055,632 | $94,496,226 | -4% | 0.15% |
| 2. | Millennium Management Israel Englander | 2,279,451 | $53,111,208 | +42% | 0.02% |
| 3. | Sarissa Capital Management Alex Denner | 2,130,950 | $49,651,135 | -25% | 31.5% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,887,570 | $43,980,381 | -20% | 0.02% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,504,411 | $35,052,776 | +9% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.13 | 62,000 | $814,196.40 | 7,277,000 | 2023-06-15 | Filing | |
| $13.05 | 8,000 | $104,384.00 | 7,215,000 | 2023-06-06 | Filing | |
| $13.04 | 7,000 | $91,296.80 | 7,207,000 | 2023-06-05 | Filing | |
| $13.01 | 120,000 | $1,560,648.00 | 7,200,000 | 2023-05-30 | Filing | |
| $13.12 | 30,000 | $393,729.00 | 7,080,000 | 2023-05-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.52 | 1,196,746 | $20,964,237.40 | 5,658,705 | 2025-03-06 | Filing | |
| $17.63 | 270,374 | $4,766,125.83 | 6,855,451 | 2025-03-05 | Filing | |
| $17.63 | 151,175 | $2,665,079.19 | 7,125,825 | 2025-03-04 | Filing | |
| $13.97 | 5,405 | $75,507.85 | 40,158 | 2023-11-15 | Filing | |
| $14.01 | 5,589 | $78,301.89 | 45,563 | 2023-11-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,307,845 | $263,472,790 | 0% | |
| 2. | 4,436,427 | $103,366,386 | 0.02% | |
| 3. | 4,224,951 | $98,441,358 | 0.01% | |
| 4. | 3,141,581 | $73,198,837 | 0% | |
| 5. | 2,024,082 | $47,161,138 | 1.08% |
News See All
Cantor Fitzgerald Lifts PT on Innoviva, Inc. (INVA) to $32 from $31 - Here's Why
Innoviva, Inc. (NASDAQ:INVA) is one of the best cheap biotech stocks to buy now. Cantor Fitzgerald lifted the price target on Innoviva, Inc.
12 Cheap Biotech Stocks to Buy Now
On February 27, Eli Casdin, Casdin Capital CEO, appeared on CNBC’s ‘Closing Bell’ to talk about the biotech sector.
Innoviva, Inc. (INVA): A Bull Case Theory
We came across a bullish thesis on Innoviva, Inc on Deep-Value Stocks’s Substack. In this article, we will summarize the bulls’ thesis on INVA.
H.C. Wainwright Lifts PT on Innoviva (INVA) to $46 From $45, Keeps a Buy Rating
Innoviva, Inc. (NASDAQ:INVA) is one of the best small cap stocks to buy with huge upside potential. Innoviva, Inc. (NASDAQ:INVA) received a rating update from H.C.
12 Small Cap Stocks to Buy with Huge Upside Potential
Talking about rotation in the market, she expects the trend to continue for a while, with the capital basically moving from the high multiple mega cap winners towards small caps, cyclicals, and the international...
Where is Innoviva (INVA) Headed According to Analysts?
Innoviva, Inc. (NASDAQ:INVA) is one of the best affordable biotech stocks to invest in now. On August 11, H.C.
12 Affordable Biotech Stocks to Invest In Now
On September 4, Mizuho healthcare strategist Jared Holz appeared on CNBC's ‘Power Lunch’ to talk about the changing sentiment in the healthcare sector, the differences in the biotech ETFs, and more...
10 Stocks with Insanely High PE Ratios Insiders Are Selling
The U.S. stock market has turned into a theater of extremes right now.
12 Best Extremely Profitable Stocks to Buy
In this piece, we will take a look at 12 best extremely profitable stocks to buy.
Hedge Fund Resource Center